Semaglutide and cardiovascular outcomes by baseline HbA1c and change in HbA1c in people with overweight or obesity but without diabetes in select
A significant advancement occurred with the creation of oral semaglutide, marking the first successful oral formulation of a GLP-1 receptor agonist
On the other hand, injectable and oral GLP-1 therapies are FDA-approved, tested in clinical settings, and are often recommended
Hormone replacement therapy, or HRT, works by restoring the hormonal signaling that menopause withdraws, supporting the mitochondrial function, tissue health, and metabolic stability that estrogen had been maintaining
But ease of use does not mean they work well, and their effectiveness falls short when compared to prescription GLP-1 drugs that have been studied and proven
At the gastric level, it slows gastric emptying and reduces both postprandial glucose excursions and gastric acid secretion